AI assistant
Sending…
IMMUCELL CORP /DE/ — Director's Dealing 2010
Mar 5, 2010
34519_dirs_2010-03-05_111b276c-f81c-466d-bfb8-8b1e71f4b729.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2010-03-03
Reporting Person: ROTHSCHILD JONATHAN E (Director, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-03-03 | Common Stock, par value $0.10 per share | P | 1000 | $3.7928 | Acquired | 458881 | Direct |
Footnotes
F1: This figure includes 189,737 shares of common stock held by Arterio, Inc., a company owned solely by Mr. Rothschild.
More from IMMUCELL CORP /DE/
Regulatory Filings
2026
May 14
Annual Report
2026
May 13
Regulatory Filings
2026
May 8
Proxy Solicitation & Information Statement
2026
Apr 24
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 8
Annual Report
2026
Mar 30
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 23